Tyler’s Law
- Bill Number
- S. 921
- Origin Chamber
- Senate
- Congress
- 119th Congress, Session 2
- Policy Area
- Health
- Status
- Passed Senate
- Latest Action
- 2026-03-24: Held at the desk.
- Last Updated
- 2026-04-08T18:35:54Z
AI-Generated Summary
Purpose
The legislation, titled "Tyler's Law," aims to improve the response to fentanyl overdoses in hospital emergency departments (EDs) by directing the U.S. Department of Health and Human Services (HHS) to study current testing practices and issue guidance on making fentanyl testing a routine procedure for patients experiencing overdoses. It seeks to balance benefits like better detection with considerations such as costs, privacy, and patient care.
Key Provisions
- Study Requirement: Within 3 years of enactment, the HHS Secretary, through the Assistant Secretary for Mental Health and Substance Use and in coordination with other federal entities or stakeholders as needed, must complete a study examining:
- How often hospital EDs test for fentanyl or related substances (and other controlled drugs) in overdose cases.
- Situations where such testing is not performed.
- Costs of fentanyl testing.
- Benefits and risks to patients from this testing.
- Needs for staff training to conduct the tests.
- Effects on patients, including privacy protections for health information (under federal regulations like HIPAA, which safeguards personal medical data) and the doctor-patient relationship.
- Barriers to implementing testing and recommendations to overcome them.
- Guidance Issuance: Within 9 months after the study, HHS must release guidance based on study findings, covering:
- Whether hospital EDs should routinely test overdose patients for fentanyl or related substances.
- Ways to ensure healthcare staff know what substances standard drug tests screen for, including fentanyl.
- How fentanyl testing might influence future overdose risks and overall patient health outcomes.
- Federal resources available to help EDs adopt such testing.
- Definitions: A "hospital emergency department" includes EDs in hospitals and independent freestanding EDs (standalone facilities providing emergency care, as defined in federal health law).
Significant Changes to Existing Law
This bill introduces new mandates for HHS to conduct a specific study and issue targeted guidance, without directly amending prior laws. It builds on existing federal efforts to combat the opioid crisis but adds a focused requirement for evaluating and promoting fentanyl-specific testing protocols in EDs, which were not previously required at this level of detail.
Potential Impacts
- Government Agencies: HHS will face administrative burdens to complete the study and guidance, potentially involving coordination with agencies like the Centers for Disease Control and Prevention (CDC) or Substance Abuse and Mental Health Services Administration (SAMHSA). This could lead to new resource allocation for public health initiatives.
- Citizens: Patients experiencing overdoses may benefit from earlier detection of fentanyl (a potent synthetic opioid often mixed with other drugs), potentially improving treatment and reducing repeat incidents. However, it could raise concerns about testing without consent or added costs passed to healthcare systems.
- International Relations: Minimal direct impact, though it indirectly supports U.S. efforts in global drug control by enhancing domestic responses to fentanyl, which is often trafficked internationally.
- Broader Effects: Hospitals may see increased operational costs and training needs, but access to federal resources could ease adoption. Overall, it could contribute to lowering overdose deaths, a major public health issue.
Main Stakeholders Affected
- Healthcare Providers: Hospital ED staff and administrators, who would need to adapt testing routines, undergo training, and manage privacy compliance.
- Patients and Families: Individuals at risk of or recovering from overdoses, particularly those affected by fentanyl, as testing could influence their care and long-term health.
- Federal Government: HHS and related agencies, responsible for executing the study, guidance, and resource support.
- Hospitals and Facilities: Including freestanding EDs, which may need to update policies and budgets.
- Advocacy Groups: Organizations focused on substance use, mental health, and patient rights, who could influence or benefit from the outcomes.
Notable Legal, Constitutional, or Political Implications
- Legal: Emphasizes compliance with existing privacy laws (e.g., HIPAA) to protect patient data during testing, avoiding potential violations of medical confidentiality. The guidance is advisory, not mandatory, so it won't impose enforceable rules but could shape voluntary standards.
- Constitutional: No major issues; it aligns with Congress's authority to regulate public health and interstate commerce under the Commerce Clause. It respects patient rights by requiring study of privacy and consent implications.
- Political: Addresses the ongoing opioid epidemic, a bipartisan priority, by targeting fentanyl—a key driver of overdose deaths—without mandating tests, allowing flexibility. It could spark debates on healthcare costs versus public safety, potentially influencing future funding for addiction treatment.
This summary was generated by AI and may contain inaccuracies. Refer to the official source document for the authoritative text.
Sponsor
Cosponsors (13)
Sen. Padilla, Alex [D-CA], Sen. Grassley, Chuck [R-IA], Sen. Warner, Mark R. [D-VA], Sen. Young, Todd [R-IN], Sen. Scott, Rick [R-FL], Sen. Mullin, Markwayne [R-OK], Sen. Kim, Andy [D-NJ], Sen. Klobuchar, Amy [D-MN], Sen. Warnock, Raphael G. [D-GA], Sen. Hassan, Margaret Wood [D-NH], Sen. Moody, Ashley [R-FL], Sen. Tuberville, Tommy [R-AL], Sen. Cantwell, Maria [D-WA]
Recent Actions
- 2026-03-24: Held at the desk.
- 2026-03-24: Received in the House.
- 2026-03-24: Message on Senate action sent to the House.
- 2026-03-23: Passed Senate with an amendment by Unanimous Consent. (consideration: CR S1559-1560; text: CR S1559-1560)
- 2026-03-23: Passed/agreed to in Senate: Passed Senate with an amendment by Unanimous Consent.
- 2026-01-28: Placed on Senate Legislative Calendar under General Orders. Calendar No. 307.
- 2026-01-28: Committee on Health, Education, Labor, and Pensions. Reported by Senator Cassidy with an amendment in the nature of a substitute. Without written report.
- 2026-01-28: Committee on Health, Education, Labor, and Pensions. Reported by Senator Cassidy with an amendment in the nature of a substitute. Without written report.
- 2026-01-15: Committee on Health, Education, Labor, and Pensions. Ordered to be reported with an amendment in the nature of a substitute favorably.
- 2025-03-10: Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
- 2025-03-10: Introduced in Senate
Bill Versions
- Tyler’s Law — issued 2026-03-23 — PDF (6 pages)
- Tyler’s Law — issued 2025-03-10 — PDF (3 pages)
- Tyler’s Law — issued 2026-01-28 — PDF (8 pages)